Heat‐Shock Protein 90 (Hsp90) as Anticancer Target for Drug Discovery: An Ample Computational Perspective

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Chemical Biology and Drug Design

• Publication date

  2015-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/cbdd.12582PMID 25958815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic Pathways and Glioblastoma Treatment: Insights From Signaling Cascades

  2015cited by this paper
• Tyrosine 251 at the C‐terminus of neuronal glycoprotein M6a is critical for neurite outgrowth

  2015cited by this paper
• Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH: comment

  2015cited by this paper
• Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease.

  2015cited by this paper
• Hsp90 Inhibitors, Part 2: Combining Ligand-Based and Structure-Based Approaches for Virtual Screening Application

  2014cited by this paper
• Predictive factors for technically difficult endoscopic submucosal dissection in the colorectum

  2014cited by this paper
• Inhibition of Ubiquitin Proteasome System Rescues the Defective Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA1) Protein Causing Chianina Cattle Pseudomyotonia* ♦

  2014cited by this paper
• BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.

  2014cited by this paper
• Clinical translation of molecular imaging agents used in PET studies of cancer.

  2014cited by this paper
• Crosstalk between kinases, phosphatases and miRNAs in cancer.

  2014cited by this paper
• Conformational Transition Pathways of Epidermal Growth Factor Receptor Kinase Domain from Multiple Molecular Dynamics Simulations and Bayesian Clustering

  2014cited by this paper
• Online supplementary information for the article ‘ Masitinib in advanced gastrointestinal stromal tumor after failure of imatinib : a randomized controlled open-label trial ’

  2014cited by this paper
• Successful imatinib therapy for neuroendocrine carcinoma with activating Kit mutation: a case study.

  2014cited by this paper
• Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

  2014cited by this paper
• Discovery and Bioevaluation of Novel Pyrazolopyrimidine Analogs as Competitive Hsp90 Inhibitors Through Shape‐Based Similarity Screening

  2014cited by this paper
• Current state-of-the-art molecular dynamics methods and applications.

  2014cited by this paper
• Role of a Janus kinase 2-dependent signaling pathway in platelet activation.

  2014cited by this paper
• Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors

  2014cited by this paper
• Bortezomib Sensitizes Primary Meningioma Cells to TRAIL-Induced Apoptosis by Enhancing Formation of the Death-Inducing Signaling Complex

  2014cited by this paper
• Arabidopsis thaliana Remorins Interact with SnRK1 and Play a Role in Susceptibility to Beet Curly Top Virus and Beet Severe Curly Top Virus

  2014cited by this paper
• Transferred BCR/ABL DNA from K562 Extracellular Vesicles Causes Chronic Myeloid Leukemia in Immunodeficient Mice

  2014cited by this paper
• Imatinib Mesylate plus Hydroxyurea Chemotherapy for Cerebellar Meningioma in a Belgian Malinois Dog

  2014cited by this paper
• ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors.

  2014cited by this paper
• Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer.

  2014cited by this paper
• Hippocampus remodeling by chronic stress accompanied by GR, proteasome and caspase-3 overexpression.

  2014cited by this paper
• FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation

  2014cited by this paper
• Prenatal breastfeeding counseling--Pregnancy Risk Assessment Monitoring System, United States, 2010.

  2014cited by this paper
• GABAB(1) receptor subunit isoforms differentially regulate stress resilience

  2014cited by this paper
• Update on Janus kinase antagonists in inflammatory bowel disease.

  2014cited by this paper
• BRAF-mutations in non-small cell lung cancer.

  2014cited by this paper
• Thyroid Cancer Study among Ukrainian Children Exposed to Radiation after the Chornobyl Accident: Improved Estimates of the Thyroid Doses to the Cohort Members

  2014cited by this paper
• Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues

  2014cited by this paper
• An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase resistance to lamivudine.

  2014cited by this paper
• Enhanced osteoblastogenesis in three-dimensional collagen gels.

  2014cited by this paper
• Compensatory Role of Double Mutation N348I/M184V on Nevirapine Binding Landscape: Insight from Molecular Dynamics Simulation

  2014cited by this paper
• Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS.

  2014cited by this paper
• Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia

  2014cited by this paper
• BRAF inhibitors in cancer therapy.

  2014cited by this paper
• Cancer screening: global debates and Cuban experience.

  2014cited by this paper
• Chapter Twenty-Five - Case History: Xeljanz™ (Tofacitinib Citrate), a First-in-Class Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis

  2014cited by this paper
• Integrated approach to structure-based enzymatic drug design: molecular modeling, spectroscopy, and experimental bioactivity.

  2014cited by this paper
• [Review of pharmacological interactions of oral anticancer drugs provided at pharmacy department].

  2014cited by this paper
• Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs

  2014cited by this paper
• Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.

  2014cited by this paper
• Molecular Pathways Molecular Pathways : Targeting Resistance in the Androgen Receptor for Therapeutic Bene fi t

  2014cited by this paper
• Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold.

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Identification and optimization of novel Hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening.

  2014cited by this paper
• Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses.

  2014cited by this paper
• Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases

  2014cited by this paper
• Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death.

  2014cited by this paper
• Cyclin-dependent kinase 5 phosphorylates and induces the degradation of ataxin-2.

  2014cited by this paper
• Ubiquitin-proteasome system controls ciliogenesis at the initial step of axoneme extension

  2014cited by this paper
• Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.

  2014cited by this paper
• Revisión de las interacciones farmacológicas de los fármacos antineoplásicos orales dispensados en un servicio de farmacia

  2014cited by this paper
• Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor

  2014cited by this paper
• Synthesis of potential allosteric modulators of Hsp90 by chemical glycosylation of Eupomatenoid-6.

  2014cited by this paper
• BRAF mutations in non-small-cell lung cancer.

  2014cited by this paper
• MDMC2: A molecular dynamics code for investigating the fragmentation dynamics of multiply charged clusters

  2014cited by this paper
• The TLR3, PI3K, survivin, FasL, and Fas genes as major risk factors of occurrence and development of cervical cancer disease.

  2014cited by this paper
• An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells.

  2014cited by this paper
• Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.

  2014cited by this paper
• [Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].

  2014cited by this paper
• High-resolution structural analysis shows how Tah1 tethers Hsp90 to the R2TP complex.

  2013cited by this paper
• Frontiers in High-Performance, Large-Scale Molecular Dynamics. 35 Years of Molecular-Dynamics Simulations of Biological Systems

  2013cited by this paper
• Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening

  2013cited by this paper
• Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.

  2013cited by this paper
• Virtual Screening and Molecular Descriptor Analysis on Dietary Phytochemicals Against Heat Shock Protein 90 Enzyme

  2013cited by this paper
• Molecular dynamics study on the free energy profile for dissociation of ADP from N-terminal domain of Hsp90

  2013cited by this paper
• Hsp90 inhibitors in breast cancer: a systematic review.

  2013cited by this paper
• Cyclophilin A Inhibition: Targeting Transition-State-Bound Enzyme Conformations for Structure-Based Drug Design

  2013cited by this paper
• Assessment of 3D models for allergen research

  2013cited by this paper
• A western blot assay to measure cyclin dependent kinase activity in cells or in vitro without the use of radioisotopes

  2013cited by this paper
• Synthesis and biological activities of a new class of heat shock protein 90 inhibitors, designed by energy-based pharmacophore virtual screening.

  2013cited by this paper
• The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction.

  2013cited by this paper
• Oxidative inhibition of Hsp90 disrupts the super‐chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo

  2013cited by this paper
• Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases.

  2013cited by this paper
• Hsp90: structure and function.

  2012cited by this paper
• In silico evaluation of modes of action of anticancer compounds on molecular targets for cancer

  2012cited by this paper
• The architecture of functional modules in the Hsp90 co‐chaperone Sti1/Hop

  2012cited by this paper
• Geldanamycin and its derivatives as Hsp90 inhibitors.

  2012cited by this paper
• Hsp90 structure and function studied by NMR spectroscopy.

  2012cited by this paper
• Binding mechanism between Hsp90 and Sgt1 explored by homology modeling and molecular dynamics simulations in rice

  2012cited by this paper
• Corresponding Functional Dynamics across the Hsp90 Chaperone Family: Insights from a Multiscale Analysis of MD Simulations

  2012cited by this paper
• Probing Molecular Mechanisms of the Hsp90 Chaperone: Biophysical Modeling Identifies Key Regulators of Functional Dynamics

  2012cited by this paper
• Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.

  2012cited by this paper
• Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells.

  2012cited by this paper
• [Treatment with imatinib for refractory PAH].

  2012cited by this paper
• Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode.

  2012cited by this paper
• Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitors

  2012cited by this paper
• Dual inhibition of chaperoning process by taxifolin: molecular dynamics simulation study.

  2012cited by this paper
• Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers.

  2012cited by this paper
• Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding

  2012cited by this paper
• Molecular Design of Anticancer Drug Leads Based on Three-Dimensional Quantitative Structure-Activity Relationship

  2011cited by this paper
• Dynamic Interaction of Hsp90 with Its Client Protein p53.

  2011influential reference
• Elucidation of the Hsp90 C-terminal inhibitor binding site.

  2011cited by this paper
• Structural analysis of the interaction between Hsp90 and the tumor suppressor protein p53

  2011cited by this paper
• Structural Determination of Three Different Series of Compounds as Hsp90 Inhibitors Using 3D-QSAR Modeling, Molecular Docking and Molecular Dynamics Methods

  2011cited by this paper
• Applying Molecular Dynamics Simulations to Identify Rarely Sampled Ligand-bound Conformational States of Undecaprenyl Pyrophosphate Synthase, an Antibacterial Target

  2011cited by this paper
• Conformational dynamics of the molecular chaperone Hsp90

  2011cited by this paper

• Synthesis and exploration of anticancer potential of spirocyclic 1,2,3-triazoline and aziridine derivatives of natural eudesmanolide isoalantolactone.

  2025cites this paper
• Development of machine learning models for the screening of potential HSP90 inhibitors

  2022cites this paper
• Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years

  2022influential citation
• Novel O-acylated (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-one oximes targeting HSP90-HER2 axis in breast cancer cells.

  2021cites this paper
• Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)

  2020cites this paper
• INSTITUTO CARLOS CHAGAS MESTRADO EM BIOCIÊNCIAS E BIOTECNOLOGIA LOUISE ULRICH KURT AN APPROACH FOR QUALITY CONTROL AND CHARACTERIZATION OF PROTEIN CONFORMERS BY USING CROSS-LINKING MASS SPECTROMETRY AND PATTERN RECOGNITION CURITIBA

  2020cites this paper
• Discovery of biogenic-based compound as potential heat-shock protein 90 inhibitor through fragment-based drug design

  2019cites this paper
• Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain

  2018cites this paper
• Computational Modeling of the Hsp90 Interactions with Cochaperones and Small-Molecule Inhibitors.

  2018cites this paper
• Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation

  2018cites this paper
• Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents.

  2017cites this paper
• Potential Ebola drug targets – filling the gap: a critical step forward towards the design and discovery of potential drugs

  2017cites this paper
• TRAP1: a viable therapeutic target for future cancer treatments?

  2017cites this paper
• Mechanism of Inhibition of Hsp90 Dimerization by Gyrase B Inhibitor Coumermycin A1 (C–A1) Revealed by Molecular Dynamics Simulations and Thermodynamic Calculations

  2016cites this paper
• Molecular docking performance evaluated on the D3R Grand Challenge 2015 drug-like ligand datasets

  2016cites this paper
• Molecular Approaches to Target Heat Shock Proteins for Cancer Treatment

  2015cites this paper
• Identification of Candidate Biomarkers by Combining Laser Capture Microdissection and Mass Spectrometry

  year unknowncites this paper